Clinical Trials Logo

Filter by:
NCT ID: NCT01119950 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Start date: April 2010
Phase: Phase 2
Study type: Interventional

This study was designed to investigate the efficacy and safety of NVA237, a long-acting muscarinic antagonist, in patients with moderate to severe COPD.

NCT ID: NCT01118624 Completed - Breast Cancer Clinical Trials

Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer

Start date: March 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the efficacy (ability to provide a beneficial treatment of the disease) of pralatrexate for the treatment of female patients with advanced or metastatic breast cancer who have failed prior chemotherapy. Patients will receive vitamin B12 and folic acid supplementation.

NCT ID: NCT01117584 Completed - Clinical trials for Type 2 Diabetes Mellitus

A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus

BALANCE
Start date: April 6, 2010
Phase: Phase 2
Study type: Interventional

Evaluate the efficacy, safety and tolerability of a 12-week treatment of 4 doses of ASP1941 compared to placebo in combination with metformin in adult patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin alone.

NCT ID: NCT01114217 Completed - Clinical trials for Iron Deficiency Anemia

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

Start date: July 27, 2010
Phase: Phase 3
Study type: Interventional

To evaluate the safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia (IDA).

NCT ID: NCT01114204 Completed - Clinical trials for Iron Deficiency Anemia

A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia

Start date: August 10, 2010
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the efficacy and safety of intravenous (IV) ferumoxytol compared to IV iron sucrose for the treatment of iron deficiency anemia (IDA).

NCT ID: NCT01114139 Completed - Clinical trials for Iron Deficiency Anemia

A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia

Start date: June 19, 2010
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and safety of intravenous (IV) ferumoxytol compared with placebo for the treatment of iron deficiency anemia (IDA).

NCT ID: NCT01113957 Completed - Ovarian Cancer Clinical Trials

A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer

Start date: March 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the objective response rate of ABT-888 when given in combination with temozolomide versus pegylated liposomal doxorubicin (PLD) alone in subjects with recurrent high grade serous ovarian cancer.

NCT ID: NCT01112306 Completed - Clinical trials for Pulmonary Arterial Hypertension

ACT-293987 in Pulmonary Arterial Hypertension

Start date: July 7, 2010
Phase: Phase 3
Study type: Interventional

Long-term, single-arm, multicenter, open-label extension, Phase 3 study, to evaluate the safety and tolerability of ACT-293987 in patients with PAH who participated in the double-blind study AC-065A302 (GRIPHON)

NCT ID: NCT01111461 Completed - Endometrial Cancer Clinical Trials

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression

Start date: March 2010
Phase: Phase 2
Study type: Interventional

To assess the objective response rate (ORR: complete response + partial response [CR+ PR]) of E7080 in subjects with unresectable endometrial cancer and disease progression following platinum-based, first-line chemotherapy. .

NCT ID: NCT01110915 Completed - Clinical trials for Magnetic Resonance Imaging

Advisa MRI Clinical Study

Start date: June 2010
Phase: N/A
Study type: Interventional

The purpose of the Advisa MRI System clinical study is to confirm safety and effectiveness in the clinical MRI (Magnetic Resonance Imaging) environment when subjects receive MRI scans up to 2W/kg Specific Absorption Rate (SAR) without positioning restrictions (MRI scans may occur anywhere on the body including the chest).